Gonadorelin is a synthetic decapeptide (a peptide consisting of ten amino acids) that is structurally and functionally identical to the naturally occurring gonadotropin-releasing hormone (GnRH). GnRH is produced by the hypothalamus in the brain and plays a crucial role in regulating the reproductive system. It acts as a signaling molecule, stimulating the pituitary gland to release two other important hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones, in turn, control the function of the gonads (testes in males, ovaries in females), influencing processes such as testosterone production, sperm maturation, ovulation, and estrogen production.
Historically, gonadorelin was used diagnostically to assess pituitary function and therapeutically in certain reproductive disorders. Its primary clinical applications have evolved over time with the development of more potent GnRH agonists and antagonists. Gonadorelin is delivered by injection, reflecting its peptide nature which would be degraded if taken orally. Its rapid half-life necessitates specific administration schedules to achieve desired effects. (PubChem, DrugBank)
Deep dive
Tap a section to expand.
Known interactions
Category rule: peptide × hormone
Note
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Frequently asked
Sources referenced
["- PubChem","- DrugBank","- NIH National Library of Medicine (NLM)","- MedlinePlus (a service of the National Library of Medicine)","- Mayo Clinic","- Cochrane Library","- Examine.com"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the peptide category or studied for the same goals.
